Marilyn Kwan to Neoplasm Metastasis
This is a "connection" page, showing publications Marilyn Kwan has written about Neoplasm Metastasis.
Connection Strength
0.084
-
Trends in HR+ metastatic breast cancer survival before and after CDK4/6 inhibitor introduction in the United States: a SEER registry analysis of patients with HER2- and HER2+ metastatic breast cancer. Breast Cancer Res Treat. 2024 Nov; 208(2):223-235.
Score: 0.058
-
The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis. Sci Rep. 2013; 3:2246.
Score: 0.026